Mersana Therapeutics, Inc. / Financial strength (Piotroski F-Value)

    The F-Value, developed by Stanford accounting professor Joseph Piotroski, measures a company's financial strength based on nine distinct criteria. Piotroski suggest using the value as part of a value investing strategy to rank stocks with a low price-to-book ratio. The approach is described in detail in Piotroski's 2002 Paper Value Investing: The Use of Historical Financial Statement Information to Separate Winners From Losers.

    Financial strength (Piotroski F-Value)
    4 / 9
    Return on assets (ROA) greater than 0
    close -87.5%
    Operating cash flow greater than 0
    close -$68.03M
    ROA greater than previous year
    close -87.5% ≤ -58.5%
    Cash flow return on assets (CFROA) greater than Return on assets (ROA)
    close -94.3% ≤ -87.5%
    Leverage ratio lower than previous year
    check 0.0% < 11.3%
    Current ratio greater than previous year
    close 135.1% ≤ 271.7%
    No new common stock issued last year
    check -$4.69M
    Gross margin greater than previous year
    check 99.2% > 97.1%
    Asset turnover greater than previous year
    check 41.1% > 16.7%

    F-Value history

    The F-Value is calculated for each quarter based on the cumulation of the previous four quarterly statements. Click on the chart to see the F-Value at a specific time in the past.

    1
    1
    1
    1
    2
    4
    4
    4
    4
    2
    4
    3
    2
    4
    1
    1
    1
    3
    3
    4
    5
    4
    6
    4
    3
    4
    3
    4
    4
    5
    4

    Notifications